$7.370
-0.361 (-4.90%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AKTX Prediction & Forecast by Similar Chart Analysis
Alphio's AKTX stock price prediction model matches the current Akari Therapeutics PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.35 (-0.26%). The 1-week path is $7.37 (+0.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Akari Therapeutics PLC Stock?
Currently, Akari Therapeutics PLC (AKTX) is not a good buy. The stock is trading at $7.37, significantly below its 52-week high of $29.32, indicating a substantial decline of 70.66% over the past year. The RSI is at 38.906, suggesting it is nearing oversold territory but not yet a strong buy signal. Furthermore, the forward P/E is 0, reflecting no earnings expected in the near term, which raises concerns about its profitability and financial health. The main risk is the negative net income, which reached -14,455,000 USD in Q1 2026, indicating ongoing financial struggles.
AKTX stock price ended at $7.37 on Friday, after losing -4.90%
Akari Therapeutics PLC (AKTX) last closed at $7.3701, losing -4.90%. These facts feed the 1-day and 1-week AKTX price prediction above.
Analyst Consensus
Akari Therapeutics PLC (AKTX): 2 buy, 1 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Akari Therapeutics PLC (AKTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches AKTX, ranked by similarity.
Seasonality analysis for AKTX
Historically the probability of a positive November return for AKTX is 0.00%. June offers the highest probability of a positive month at 50.00%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AKTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.90 | $1.01 | $1.23 | -86.32% |
| Dec 2026 | $1.21 | $1.24 | $1.46 | -83.24% |
In 2026, Akari Therapeutics PLC (AKTX) is projected to range from $0.90 to $1.46.
Akari Therapeutics PLC 2026 monthly forecast
In Nov 2026, Akari Therapeutics PLC is projected to average $1.01, with a low of $0.90 and high of $1.23.
In Dec 2026, Akari Therapeutics PLC is projected to average $1.24, with a low of $1.21 and high of $1.46.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.